CAR T Cell Therapy Market is Expected to Grow at a CAGR of 20.9% during the forecast period of 2023-2030 : Cognitive Market Research

Market Overview:
- Chimeric antigen receptor (CAR) T-cell therapy is a kind of immunotherapy that modifies the immune system of a cancer patient to more effective at identifying and destroying cancer cells.

Summary:
• As per Cognitive Market Research, the global CAR T cell therapy market is estimated to be valued at $ 2,259.5 million in 2022 and is expected to exhibit a CAGR of 20.9% during the forecast period.
• The North American region is expected to drive the highest CAGR during the forecast period.

"To know more The CAR T Cell Therapy Market statistics click here: https://www.cognitivemarketresearch.com/car-t-cell-therapy-market-report

Market Dynamics:
- The rising incidence of cancer and increasing number of serious patients is expected to drive the global CAR-T cell market. Growing public awareness about healthcare and well-being, government support and increasing volumes of T-Cell therapy applications are expected to fuel the market's expansion. Furthermore, the development of new technology and increasing awareness regarding CAR-T cell therapy will provide the opportunity for the growth of the market. However, concerns about cell therapy's side effects and additional neurological issues are expected to restrain the market growth.

Market Segmentation:
Drug type:
• Axicabtagene Ciloleucel
• Tisagenlecleucel
• Brexucabtagene Autoleucel
• Others

Indication:
• Lymphoma
• Acute Lymphocytic Leukemia
• Others

End user:
• Hospitals
• Cancer Treatment Centers

The Major Players in CAR T Cell Therapy Market are:
Autolus Therapeutics, Bluebird bio Inc., Bristol-Myers Squibb, Caribou Biosciences Inc., Cartesian Therapeutics Inc., Celgene Corporation, Cellectis, Celyad Oncology, Gilead Sciences Inc.(Kite Pharma Inc.), Intellia Therapeutics, Juno Therapeutics Inc., Merck & Co. Inc., Miltenyi Biotech, Novartis AG, Pfizer Inc., Sorrento Therapeutics Inc.

Get free sample pages of latest published CAR T Cell Therapy Market Report:
https://www.cognitivemarketresearch.com/car-t-cell-therapy-market-report#request_sample

Regional Analysis:
- The North American region is expected to drive the highest revenue share during the forecast period. This is attributed to an increase in the number of life sciences businesses working on the research and commercialization of CAR T-cells, as well as developments in quality control systems. Further, Asia Pacific is the second largest in terms of revenue during the forecast period, due to high advancement in the medical sectors.

News:
- February 2022
CARsgen Therapeutics opened its first US cGMP manufacturing facility in North Carolina for producing CAR-T-cell products.
CARsgen is a biopharmaceutical company with operations in China and the U.S. The company announced that they open a new U.S. cGMP Facility for CAR-T production which focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors.

Browse here for Full TOC:
Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)
Chapter 1 Industrial Insight and Market Scope
• 1.1 Global CAR T Cell Therapy Industry Introduction
• 1.2 Objectives of the Study
• 1.3 USP of the Report
• 1.4 Who is this report for?
• 1.5 Designing of Market Scope
1.5.1 Segmentation
1.5.1 Regional Fragmentation
1.5.1 Market Players
• 1.6 Report Duration
Chapter 2 Research Methodology
Chapter 3 Executive Summary
Chapter 4 Global CAR T Cell Therapy Market Overview
Chapter 5 Competitive Analysis (Subject to Availability)
• 5.1 Global CAR T Cell Therapy Market Revenue and Share by Manufacturers (2018-2022)
• 5.2 Global Mergers and Acquisition Analysis
• 5.2 Global New Launches Analysis
Chapter 6 Qualitative Analysis
Chapter 7 Company Profiling (Subject to Availability)
Chapter 8 Global CAR T Cell Therapy Market by Drug type Segmentation Analysis (2018-2030)
Chapter 9 Global CAR T Cell Therapy Market by Indication Segmentation Analysis (2018-2030)
Chapter 10 Global CAR T Cell Therapy Market by End user Segmentation Analysis (2018-2030)
Chapter 11 Global CAR T Cell Therapy Market Regional Analysis
Chapter 12 North America CAR T Cell Therapy Market Outlook (2018 - 2030)
Chapter 13 Europe CAR T Cell Therapy Market Outlook (2018 - 2030)
Chapter 14 Asia Pacific CAR T Cell Therapy Market Outlook (2018 - 2030)
Chapter 15 Latin America CAR T Cell Therapy Market Outlook (2018 - 2030)
Chapter 16 Middle East and Africa CAR T Cell Therapy Market Outlook (2018 - 2030)
Chapter 17 Research Findings

To know more CAR T Cell Therapy Market TOC click here: https://www.cognitivemarketresearch.com/car-t-cell-therapy-market-report#table_of_contents

Related Report
• Stem cell assay market - https://www.cognitivemarketresearch.com/stem-cell-assay-market-report
• Cell viability assay market - https://www.cognitivemarketresearch.com/cell-viability-assays-market-report
• Acute Myeloid Leukemia Treatment Market - https://www.cognitivemarketresearch.com/acute-myeloid-leukemia-treatment-market-report
• 3D Cell Culture Market - https://www.cognitivemarketresearch.com/3d-cell-culture-market-report

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Nicolas Shaw
Cognitive Market Research
20 N State Street,Chicago,
Illinois, 60602
United States
USA: +1 312-376-8303
Europe and UK: (+44) 20-8144-9523
Asia Pacific: (+852) 81930785
Email: sales@cognitivemarketresearch.com
Website: https://www.cognitivemarketresearch.com/about-us

About Cognitive Market Research Company :
Cognitive Market Research has evolved as one leading market research and consulting firm and it provides services across multiple domains. Cognitive Market Research gathers and analyzes data about customers, competitors, distributors, and other market actors and forces operational across the value chain. As a market research company, we follow a complete process of gathering information about the target market and end-use industries to verify the complete journey of the product or service in the global market. It helps our readers understand the demand and viability of their product/service and how it might perform in the real world and help them to build business strategies accordingly.

This release was published on openPR.